Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Sensory Cloud Inc.

Sensory Cloud Announces Positive Results in Phase 2a REACH Study in Patients with Refractory Chronic Cough (RCC)
From Sensory Cloud Inc.
Via Business Wire
REACH Trial Evaluating First-Line Treatment of Refractory Chronic Cough Completes Enrollment
From Sensory Cloud Inc.
Via Business Wire
Sensory Cloud Inc. and Hyfe Inc. Release Study on Inhaled Treatment for Refractory Chronic Cough
From Sensory Cloud Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.